Scientists Identify Alzheimer’s Disease-Protective Genetic Factors and Unravel Disease Mechanisms
On Feb. 4, 2025, an international research teams led by Hong Kong University of Science and Technology (HKUST)…
Biotechnology | Disease | FDA | Neurology | Ophthalmogy | Therapeutics
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
On Feb. 4, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Susvimo® (ranibizumab…
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
On Feb. 3, 2025, a team of Caltech engineers announced they have developed a technique for inkjet printing…
TGen researchers create spatial map of gene expression in pulmonary fibrosis
On Feb. 3, 2025, a team of researchers co-led by TGen, part of City of Hope announced creating…
United Therapeutics Announces FDA Clearance of Pig Transplantation Clinical Trial
On Feb. 3, 2025, United Therapeutics, a public benefit corporation, announced that the U.S.Food and Drug Administration (FDA)…
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
‘Breakthrough’ stem-cell patches strengthened a woman’s failing heart
On Jan. 29, 2025, researchers from the University Medical Center Göttingen announced they have shown that patches of…
Biotechnology | Disease | FDA | Therapeutics
FDA approves Ozempic® (semaglutide) as only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
On Jan. 28, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to…
A genome-wide atlas of cell morphology revealed gene functions
On Jan. 27, 2025, researchers at the Broad Institute of MIT and Harvard, along with collaborators at Calico…
Biotechnology | Diagnostics | Disease | FDA | Medicine | Neurology | NIH | Oncology | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. FDA drops Support improving clinical trial diversity
Jan. 24, 2025, the U.S. Food and Drug Administration (FDA) pulled draft guidance from its website requiring companies…
SIDS Discovery Could ID Babies at Risk
On Jan. 22, 2025, researchers from the University of Virginia School of Medicine reported revealing the fingerprints of…
PET probe images inflammation with high sensitivity and selectivity
On Jan. 22, 2025, researchers at Dana-Farber Cancer Institute announced they have developed a breakthrough method to detect…
FDA approved SPRAVATO® (esketamine) in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
On Jan. 21, 2025, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of a…
huge study highlights new health risks of Obesity drugs
On Jan. 20, 2025, an analysis of data from nearly 2 million people has revealed new insights into…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Study pinpoints depression genes across ethnicities
On Jan. 14, 2025, an international research team led by the University of Edinburgh reported new genetic risk…
United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
Research Highlights Trends in ADHD Diagnoses
On Jan. 13, 2025, new research identifies differing trends in attention-deficit/hyperactivity disorder (ADHD) diagnoses among adolescents and adults,…
University of Queensland manufactures 3D printed scaffolding to rebuild jaw bones
On Jan. 9, 2025, clinicians from the The University of Queensland (UQ) announced they had successfully used custom-made…
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
On Jan. 7, 2025, IBIO an AI-driven innovator of precision antibody immunotherapies, in collaboration with AstralBio announced the…
Genetic cause for main type of hearing loss in children with Down syndrome identified
On Jan. 7, 2025, researchers at the Francis Crick Institute, MRC Harwell Institute and UCL Queen Square Institute…
Biotechnology | Diagnostics | Disease | Infectious Disease | Influenza | Therapeutics | Vaccine | WHO
acute respiratory infections increasing in the Northern Hemisphere
On Jan. 7, 2025, the World Health Organization (WHO) reported that trends in acute respiratory infections (ARI) in…
Tufts Research suggests Connection Between Concussions, Viruses, and Alzheimer’s
On Jan. 7, 2025, researchers at Tufts University and Oxford University announced they have uncovered mechanisms connecting trauma…
Biotechnology | Diagnostics | Disease | FDA | Neurology
FDA Issues Final Guidance for Industry on Action Levels for Lead in Processed Food for Babies and Young Children
On Jan. 6, 2025, the U.S. Food and Drug Administration (FDA) issued guidance for industry on the action…
Agriculture | Chemical | Diagnostics | Disease | Neurology | NIH | Non-Profit Research | Therapeutics
Scripps Research uses Virtual chemistry to speed up drug discovery
On Jan. 3, 2025, scientists from Scripps Research reported that by using computer modeling to predict chemical reactions,…
U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk
On Jan. 3, 2025, the U.S. General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol…
AI can improve ovarian cancer diagnoses
On Jan. 2, 2025, an international study led by researchers at Karolinska Institutet in Sweden shows that AI-based…
Ancient DNA unlocks new understanding of migrations in the first millennium AD
On Jan. 1, 2025, a study led by the Francis Crick Institute showed that waves of human migration…
New Research Identifies Key Cellular Mechanism Driving Alzheimer’s Disease
On Dec. 23, 2024, researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC)…
Propranolol reduces tremors in Parkinson’s disease
On Dec. 23, 2024, a study from Radboud University reported that the standard medication levodopa does not always…
FDA Approved First Medication for Obstructive Sleep Apnea
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…